APA (7th ed.) Citation

LR, D., N, B., B, C., S, M., TA, B., & RC, B. (2025). Prevention of acute systemic reaction during LDL apheresis post COVID-19 by icatibant pretreatment. Journal of clinical lipidology, 19(4), 1153. https://doi.org/10.1016/j.jacl.2025.03.008

Chicago Style (17th ed.) Citation

LR, Davidson, Baecher N, Cheung B, McIntosh S, Bingemann TA, and Block RC. "Prevention of Acute Systemic Reaction During LDL Apheresis Post COVID-19 by Icatibant Pretreatment." Journal of Clinical Lipidology 19, no. 4 (2025): 1153. https://doi.org/10.1016/j.jacl.2025.03.008.

MLA (9th ed.) Citation

LR, Davidson, et al. "Prevention of Acute Systemic Reaction During LDL Apheresis Post COVID-19 by Icatibant Pretreatment." Journal of Clinical Lipidology, vol. 19, no. 4, 2025, p. 1153, https://doi.org/10.1016/j.jacl.2025.03.008.